SIASUN(SZ:300024) Zheng Quan Shi Bao Wang·2025-12-04 10:49Core Viewpoint - Shurui Robotics, a high-tech medical device company specializing in minimally invasive laparoscopic surgical robots, has initiated the listing guidance process with the Beijing Securities Regulatory Bureau, supported by CITIC Securities [1]. Group 1: Company Overview - Shurui Robotics was founded by Professor Xu Kai from Shanghai Jiao Tong University, focusing on the independent research, production, and commercialization of advanced laparoscopic surgical robot systems and related instruments [1]. - The company has established manufacturing bases in Beijing and an innovation center in Shanghai, aiming for a global leading position in the market [1]. Group 2: Technology and Product Development - Shurui Robotics has developed a single-port laparoscopic surgical robot that incorporates a unique super-elastic nickel-titanium alloy snake-like surgical instrument, achieving significant technological advancements [2]. - The robot received approval from the National Medical Products Administration (NMPA) in June 2023, becoming the first in China to cover urology and gynecology laparoscopic procedures, filling a domestic market gap [2]. - In May 2023, the robot's application scope was expanded to include general surgery and thoracic surgery, making it the only single-port surgical robot in China to cover these four surgical fields [2]. Group 3: Intellectual Property and Market Position - As of April 2025, Shurui Robotics has filed over 805 patents globally, establishing a comprehensive intellectual property protection system [1]. - The company is recognized as a leading player in the domestic single-port minimally invasive laparoscopic surgical robot market, receiving support from various government agencies and notable investment firms [1]. Group 4: Ownership Structure - Xu Kai directly holds 22.74% of Shurui Robotics and indirectly controls an additional 31.84% through various partnerships, totaling 54.58% of the voting rights [3].